NGN Capital Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 7
- Investments
- 58
- Portfolio
- 7
- Exits
- 27
NGN Capital General Information
Description
NGN Capital is a venture capital firm dedicated to healthcare investing, focusing on ventures with the potential to achieve above average private equity returns with an emphasis on later stage investments. The firm is based in New York, New York and was founded in 2003.
Contact Information
Website
www.ngncapital.com
Year Founded
2003
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- 369 Lexington Avenue
- 26th Floor
- New York, NY 10017
- United States
+1 (212) 000-0000
NGN Capital Investments (58)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| OptiScan | 20-Mar-2019 | Later Stage VC | 0000 | Monitoring Equipment | Bankruptcy: Admin/Reorg | 0000000 0000000000 |
| 0000000 0000000000 | 05-Jul-2017 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | 00000 000000 00.0 |
| 0000000 0000000000 | 07-Jan-2016 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | 00000 000000 00.0 |
| 000000 0000000 | 23-Jul-2014 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue/Not Profitable | |
| 0000000 0000000000 | 12-Mar-2014 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | 00000 000000 00.0 |
| 0000 0000000 00000 | 05-Mar-2014 | 00000 00000 | 00.00 | Business/Productivity Software | Generating Revenue | |
| 000000000 | 05-Mar-2013 | 00000 00000 | 000.00 | Surgical Devices | Generating Revenue | 00000 000000 00.0 |
| 0000000000 | 12-Dec-2012 | 00000 00000 | 0000 | Other Healthcare Technology Systems | Generating Revenue | 0000000 0000000000 |
| PIN Pharma | 01-Jan-2012 | Early Stage VC | 00.000 | Biotechnology | Generating Revenue | 0000 0000000 |
| SpineView | 21-Oct-2011 | Later Stage VC | 0000 | Surgical Devices | Out of Business |
NGN Capital Exits (27)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| OptiScan | 02-Jun-2020 | Bankruptcy: Admin/Reorg | |
| 000000 0000000 | 06-Mar-2020 | 000 | 00000 |
| 0000000 0000000000 | 01-Aug-2018 | 000000000000000000 | 00000 |
| 0000000 000000 | 23-Jan-2017 | 000000000000000000 | 00000 |
| 000000000 | 01-Oct-2016 | 000000000000000000 | 00.000 |
| 000000 000000 | 30-Sep-2016 | 000 | |
| 000 0000000 | 01-Sep-2015 | 000 00 00000000 | |
| 00000 0000 0000000 | 06-Oct-2014 | 000000000000000000 | 00000 |
| Endosense | 19-Aug-2013 | Merger/Acquisition | 00000 |
| EKOS | 08-Jul-2013 | Merger/Acquisition | 00000 |
NGN Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is available in the PitchBook Platform. To explore NGN Capital‘s full profile, request access.
Request a free trialNGN Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialNGN Capital Team (20)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Alexander Cuomo | Chief Financial Officer | New York, NY | |||
| Kenneth Abramowitz | Co-Founder & Managing General Partner | 00 | 0 | 0 | New York, NY |
| John Costantino JD | Managing General Partner | 0 | 0 | 0 | New York, NY |
| Peter Johann Ph.D | Managing General Partner | 0 | 0 | 0 | Heidelberg, Germany |
| Ivica Cerina Ph.D | Partner | 0 | New York, NY |
NGN Capital Co-Investors (12)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Arcus Ventures | 1 | 0 | 0 |
|
|
| FORBION | 0 | 0 | 0 |
|
|
| Tiger Global Management | 0 | 0 | 0 |
|
|
| Wexford Capital | 0 | 0 | 0 |
|
|
| b-to-v Partners | 0 | 0 | 0 |
|
|